Control of microglial neurotoxicity by the fractalkine receptor
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor (CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1-/- mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1-/- mice showed more extensive neuronal cell loss than Cx3cr1+ littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Microglia were labeled using the CX3CR1+/GFP mouse line in which all microglia express EGFP under the control of fractalkine receptor, CX3CR1, expression (Figure 1, S1, and S5) (Cardona et al., 2006; Jung et al., 2000; Saederup et al., 2010).”
From Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner (2012) · cites this paper as Cardona et al., 2006
In the citing paper
“microglia are uniformly CX3CR1+ from early embryonic time points through adulthood (Cardona et al., 2006; Ginhoux et al., 2010; Schulz et al., 2012)”
From Differential roles of microglia and monocytes in the inflamed central nervous system (2014) · cites this paper as Cardona et al., 2006
In the citing paper
“Conflicting evidence in the literature suggests either neurotoxic or neuroprotective effects of CX3CR1 deletion in various disease models (Cardona et al., 2006; Fuhrmann et al., 2010).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“Our findings support the concept that fractalkine through its receptor CX3CR1 (Harrison et al., 1998) acts as a repressor of microglia activation (Cardona et al., 2006).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“While CX3CR1 is expressed by many leukocyte cell types in the periphery, 15 in the brain CX3CR1 is exclusively expressed by microglia 13 whereas CX3CL1 is highly expressed within neurons.14”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [13]
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundMicroglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“In response to injury, microglial cells undergo rapid morphological and functional activation and acquire properties of mature myeloid cells, including antigen presentation, reactive species generation, matrix metalloproteinase (MMP) expression and phagocytosis, as well as cytokine and growth factor secretio”
BackgroundATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundSelf-citationBlood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391 · cited 1×
“However, peripheral immune and inflammatory reactions are mostly unaltered in Cx3cr1 −/− or Cx3cl1 −/− mic”
BackgroundSelf-citationJung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Self-citationThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Based on these and other findings, efforts to develop pharmacological inhibitors of CX3CR1 are in progres”
BackgroundSelf-citationCX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,611 · cited 2×
“Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.”
BackgroundSelf-citationMicroglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · cited 1×
“Results Neuronal damage in Cx3cr1 −/− mice after systemic LPS We first examined the GFP + population in the CNS of Cx3cr1 GFP mice and found that green fluorescent cells overlapped precisely with brain cells expressing microglial markers such as ionized calcium-binding adapter molecule-1 (IBA-1”
BackgroundHarrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176 · cited 1×
“dtd" [ ]> CX3CR1 is expressed by monocytes, dendritic cells (DCs), and subsets of T cells and natural killer cells in the circulation and by microglia in the central nervous system (CNS”
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 1×
“Knockdown of TREM2 in mouse microglia impairs their phagocytic activity and enhances inflammatory gene expression, suggesting a mechanism for the human disorde”
Background
Cited by
Items 401–500 of 1,003
Translocator Protein 18 kDa Negatively Regulates Inflammation in Microglia
Bae, K.-R., Shim, H.-J., Balu, D., Kim, S. R., & Yu, S. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9540-6 · Cited by 131
“…normal conditions, microglia are maintained in a quiescent state, whereas upon detection of microbial invasion or tissue damage, microglia rapidly initiate an inflammatory response that serves to maintain tissue homeostasis and initiate repair processes (Cardona et al. 2006; Jeong et al. 2013).”
BackgroundWoodling, N. S., Wang, Q., Priyam, P. G., Larkin, P., Shi, J., Johansson, J. U., Zagol-Ikapitte, I., Boutaud, O., & Andreasson, K. I. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0410-14.2014 · Cited by 112
“Of these, signaling through the fractalkine receptor, CX3CR1, has been most extensively studied (Cardona et al., 2006; Lee et al., 2010).”
BackgroundInnate Inflammation in Parkinson's Disease
Perry, V. H. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009373 · Cited by 114
“In recent years it has been shown that there are diverse ligands expressed on (CD200, CD47, sialic acids) or secreted by (CX3CL1) neurons that bind to receptors on microglia (CD200R, CD172a; siglecs) (Hoeck et al. 2000; Barclay and Brown 2006; Cardona et al. 2006).”
Microglial Priming as Trained Immunity in the Brain
Haley, M. J., Brough, D., Quintin, J., & Allan, S. M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2017.12.039 · Cited by 104
Miyake, T., Shirakawa, H., Nakagawa, T., & Kaneko, S. (2015) · Glia · doi:10.1002/glia.22854 · Cited by 112
Masuda, T., Croom, D., Hida, H., & Kirov, S. A. (2011) · Glia · doi:10.1002/glia.21220 · Cited by 112
“We used only heterozygous [CX3CR1-EGFP] mice in all experiments to preserve CX3CR1 signaling that affects microglia-neuron interactions (Cardona et al., 2006; Ransohoff and Cardona, 2010).”
MethodGraham, L. C., Harder, J. M., Soto, I., de Vries, W. N., John, S. W. M., & Howell, G. R. (2016) · Scientific Reports · doi:10.1038/srep21568 · Cited by 112
Ramírez, K., Trías, J. F., & Sheridan, J. F. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_25 · Cited by 126
Protective Microglia and Their Regulation in Parkinson’s Disease
Le, W., Wu, J., & Tang, Y. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00089 · Cited by 112
“This was also seen in an MPTP-intoxicated CX3CR1-null mouse model (Cardona et al., 2006), suggesting that CX3CR1 signaling is important in protecting neurons against microglial neurotoxicity.”
BackgroundGamo, K., Kiryu-Seo, S., Konishi, H., Aoki, S., Matsushima, K., Wada, K., & Kiyama, H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2920-08.2008 · Cited by 111
“Intriguingly, the present study revealed that RANTES has a similar function in which productions of IL-6, IL-1 , TNF- , and iNOS were suppressed in LPS-activated microglia in vitro, although the precise mechanism underlying the suppression was unknown.”
BackgroundInfluentialThe role of microglia at synapses in the healthy CNS: novel insights from recent imaging studies
Tremblay, M.-È. (2011) · Neuron Glia Biology · doi:10.1017/s1740925x12000038 · Cited by 112
Central nervous system myeloid cells as drug targets: current status and translational challenges
Biber, K. P. H., Möller, T., Boddeke, E., & Prinz, M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.14 · Cited by 116
Microglial interactions with the neurovascular system in physiology and pathology
Zhao, X., Eyo, U. B., Murugan, M., & Wu, L. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22576 · Cited by 111
“Interestingly, a selective inactivation of microglial CX3CR1 that has been reported to regulate microglial migration (Cardona et al., 2006; Liang et al., 2009), significantly reduce blood extravasation (Jolivel et al., 2015).”
BackgroundLauro, C., Di Angelantonio, S., Cipriani, R., Sobrero, F., Antonilli, L., Brusadin, V., Ragozzino, D., & Limatola, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7590 · Cited by 110
“Although microglia-induced neurotoxicity has been, at least in part, explained by the production of cytokines and reactive oxygen species that follows microglia overactivation (19), the mechanisms underlying the neuroprotective activity of microglia likely involve the production of a number of growth factors that poss…”
BackgroundTime-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injury
Febinger, H. Y., Thomasy, H. E., Pavlova, M. N., Ringgold, K. M., Barf, P. R., George, A. M., Grillo, J. N., Bachstetter, A. D., Garcia, J. A., Cardona, A. E., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0386-5 · Cited by 110
“Indeed, deleting CX3CR1 [4] exacerbates microglial neurotoxicity induced by systemic inflammation in rodent models of Parkinson’s disease and amyotrophic lateral sclerosis [5].”
Self-citationMicroglia and inflammation: conspiracy, controversy or control?
Fernandes, A., Miller-Fleming, L., & Pais, T. F. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1670-8 · Cited by 103
“CX3CR1-deficient mice injected with LPS secrete higher levels of IL-1b and are neurotoxic [80].”
BackgroundG protein-coupled receptors as targets for anti-diabetic therapeutics
Oh, D. Y., & Olefsky, J. M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.4 · Cited by 117
Mesenchymal Stem Cells Modulate the Functional Properties of Microglia via TGF-β Secretion
Noh, M. Y., Lim, S. M., Oh, K.-W., Cho, K.-A., Park, J., Kim, K.-S., Lee, S.-J., Kwon, M.-S., & Kim, S. H. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0217 · Cited by 110
The role of microglia and their CX3CR1 signaling in adult neurogenesis in the olfactory bulb
Reshef, R., Kudryavitskaya, E., Shani-Narkiss, H., Isaacson, B., Rimmerman, N., Mizrahi, A., & Yirmiya, R. (2017) · eLife · doi:10.7554/elife.30809 · Cited by 110
“DOI: https://doi.org/10.7554/eLife.30809 11 of 30 (Cardona et al., 2006; Wolf et al., 2013).”
InfluentialAugusto‐Oliveira, M., Arrifano, G. P., Delage, C. I., Tremblay, M., Crespo‐Lopez, M. E., & Verkhratsky, A. (2022) · Biological Reviews · doi:10.1111/brv.12797 · Cited by 107
“Simultaneously, microglia express numerous receptors for neurotransmitters, neuromodulators and neurohormones; these receptors co-exist with a full complement of macrophage-characteristic immune receptors for damage- and pathogen-associated molecular patterns (DAMPs and PAMPs, respectively) (Kielian, 2006; Pocock &Ket…”
BackgroundAnimal Models of Retinal Disease
Fletcher, E. L., Jobling, A. I., Vessey, K. A., Luu, C. D., Guymer, R. H., & Baird, P. N. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00006-6 · Cited by 119
“Mice that lack expression of CX3CR1 are known to develop neurodegeneration more rapidly, suggesting that fractalkine may be an important chemokine for limiting neuronal loss.(216) Retinae of aged CX3CR1 null mice show progressive accumulation of microglia in the subretinal space that was accompanied by drusenoid lesio…”
BackgroundReceptors, Ion Channels, and Signaling Mechanisms Underlying Microglial Dynamics
Madry, C., & Attwell, D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.637157 · Cited by 109
“This is surprising as CX3CR1 receptor deficiency is known to transform microglia from a quiescent surveillance state into an activated state (65), with a larger cell soma and greatly reduced number of processes that are much shorter and less motile.”
BackgroundApolloni, S., Amadio, S., Montilli, C., Volonte, C., & D'Ambrosi, N. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt259 · Cited by 109
Raoul, W., Auvynet, C., Camelo, S., Guillonneau, X., Feumi, C., Combadière, C., & Sennlaub, F. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-87 · Cited by 109
“Neuronal cell toxicity caused by the prolonged presence of activated Cx3cr1 MCs in the brain has been described as a mechanism of neurodegenerative diseases [65].”
BackgroundBocarsly, M. E., Jiang, W.-C., Wang, C., Dudman, J. T., Ji, N., & Aponte, Y. (2015) · Biomedical Optics Express · doi:10.1364/boe.6.004546 · Cited by 119
Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy
Nash, K. R., Lee, D. C., Hunt, J. B., Morganti, J. M., Selenica, M.-L., Moran, P., Reid, P., Brownlow, M., Guang-Yu Yang, C., Savalia, M., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.011 · Cited by 108
“CX3CR1 has been reported to be necessary for cell death in a mouse model of AD (Fuhrmann et al., 2010), but it has also been shown that loss of CX3CR1 exacerbates neurodegeneration (Cardona et al., 2006).”
BackgroundNeuron-microglia signaling: Chemokines as versatile messengers
Biber, K., Vinet, J., & Boddeke, H. W. G. M. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.012 · Cited by 108
“In contrast, microglial neurotoxicity can occur in case of overshooting and uncontrolled stimulation of microglia (van Rossum and Hanisch, 2004; Cardona et al., 2006) or when microglia function is impaired (Biolee et al., 2006; Streit et al., 2006; Neumann and Takahashi, 2007).”
BackgroundFractalkine Over Expression Suppresses α-Synuclein-mediated Neurodegeneration
Nash, K. R., Moran, P., Finneran, D. J., Hudson, C., Robinson, J., Morgan, D., & Bickford, P. C. (2015) · Molecular Therapy · doi:10.1038/mt.2014.175 · Cited by 108
“Discussion: Disruption of fractalkine signaling has been shown to be detrimental in a number of neurological disorders including PD [29, 37].”
BackgroundAstrocytes modulate the chemokine network in a pathogen-specific manner
McKimmie, C. S., & Graham, G. J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.111 · Cited by 124
Progressive multiple sclerosis
Bradl, M., & Lassmann, H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0182-3 · Cited by 108
“This molecule is produced and released by intact neurons [87, 88], and its interaction with the fractalkine receptor (CX3CR1) on microglia cells suppresses microglial neurotoxicity both in vitro [89] and in vivo [88].”
BackgroundReperfusion brain injury: Focus on cellular bioenergetics
Pundik, S., Xu, K., & Sundararajan, S. (2012) · Neurology · doi:10.1212/wnl.0b013e3182695a14 · Cited by 121
“36,37 A variety of molecular signals released from dead cells, so-called danger-associated molecular pattern molecules (DAMPs), activate pattern recognition receptors including Toll-like receptors expressed on microglia.”
BackgroundProgranulin is a chemoattractant for microglia and stimulates their endocytic activity
Pickford, F., Marcus, J., Camargo, L. M., Xiao, Q., Graham, D., Mo, J.-R., Burkhardt, M., Kulkarni, V., Crispino, J., Hering, H., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.002 · Cited by 107
Bar, E., & Barak, B. (2019) · Glia · doi:10.1002/glia.23637 · Cited by 107
“Interestingly, a recent study identified a rare variant of the microglia-specific CX3CR1 gene and suggested its role in some pathophysiological mechanisms of ASD and schizophre- nia (Ishizuka et al., 2017).”
BackgroundInfluentialMicroglia control glutamatergic synapses in the adult mouse hippocampus
Basilico, B., Ferrucci, L., Ratano, P., Golia, M. T., Grimaldi, A., Rosito, M., Ferretti, V., Reverte, I., Sanchini, C., Marrone, M. C., et al. (2022) · Glia · doi:10.1002/glia.24101 · Cited by 107
“Similarly, one week of microglial depletion, achieved using the tamoxifen-inducible CX3CR1CreER to drive diphtheria toxin receptor expression in microglia, impaired learning in both fear conditioning and the NOR task (Parkhurst et al, 2013).”
BackgroundInfluentialBIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia
Sudwarts, A., Ramesha, S., Gao, T., Ponnusamy, M., Wang, S., Hansen, M., Kozlova, A., Bitarafan, S., Kumar, P., Beaulieu-Abdelahad, D., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00535-x · Cited by 104
“The LPS response captured by PC2 was most pronounced in Cx3cr1CreER mice, consistent with the previous characterization that signaling through CX3CR1 controls microglial activation [61].”
ResultMicroglial transplantation increases amyloid‐β clearance in Alzheimer model rats
Takata, K., Kitamura, Y., Yanagisawa, D., Morikawa, S., Morita, M., Inubushi, T., Tsuchiya, D., Chishiro, S., Saeki, M., Taniguchi, T., et al. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.009 · Cited by 106
“suggest that the signaling of P2X7 receptors [20] and the fractalkine receptor [21] may play a key role in microglial neuroprotection and the attenuation of microglial neurotoxicity,”
BackgroundLauro, C., Cipriani, R., Catalano, M., Trettel, F., Chece, G., Brusadin, V., Antonilli, L., van Rooijen, N., Eusebi, F., Fredholm, B. B., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.26 · Cited by 117
“experimental models of neuropathologies like experimental autoimmune encephalomyelitis (EAE), 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine hydrochloride (MPTP) striatal injection, lipopolysaccharide (LPS) administration and superoxide dismutase (SOD1) mutation (Huang et al., 2006; Cardona et al., 2006).”
BackgroundThe Pathogenesis of Glaucoma in the Interplay with the Immune System
Rieck, J. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-9781 · Cited by 105
Cx3cr1- deficient microglia exhibit a premature aging transcriptome
Gyoneva, S., Hosur, R., Gosselin, D., Zhang, B., Ouyang, Z., Cotleur, A. C., Peterson, M., Allaire, N., Challa, R., Cullen, P., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900453 · Cited by 103
“…in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of Parkinson ’ s disease and in tauopathies such as frontotemporal dementia, but promotes amyloid clearance in models of amyloid β deposition (Cardona et al, 2006; Bhaskar et al, 2010; Lee et al, 2010; Liu et al, 2010).”
InfluentialSelf-citationPoniatowski, Ł. A., Wojdasiewicz, P., Krawczyk, M., Szukiewicz, D., Gasik, R., Kubaszewski, Ł., & Kurkowska-Jastrzębska, I. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9787-4 · Cited by 104
“However, in conditions like Parkinson’s disease or amyotrophic lateral sclerosis (ALS), CX3CL1 deficiency is associated with the worst outcome [206, 207].”
BackgroundMakinde, H. M., Cuda, C. M., Just, T. B., Perlman, H. R., & Schwulst, S. J. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700896 · Cited by 104
“However, this deficiency does not impair classical monocyte migration and infiltration to the site of injury after TBI (48, 49).”
BackgroundAnalyses of phenotypic and functional characteristics of CX3CR1‐expressing natural killer cells
Hamann, I., Unterwalder, N., Cardona, A. E., Meisel, C., Zipp, F., Ransohoff, R. M., & Infante‐Duarte, C. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03409.x · Cited by 104
Self-citationAnti-inflammatory treatments for stroke: from bench to bedside
Drieu, A., Levard, D., Vivien, D., & Rubio, M. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418789854 · Cited by 102
Melzer, N., Meuth, S. G., & Wiendl, H. (2009) · The FASEB Journal · doi:10.1096/fj.09-136200 · Cited by 102
“Neurons also secrete the chemokine fractalkine and CD22, both of which attenuate microglial activity by binding to their receptors, CX3CR1 and CD45 (93, 94).”
BackgroundSato, E., Shick, H. E., Ransohoff, R. M., & Hirose, K. (2009) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-009-0198-3 · Cited by 113
Self-citationVujosevic, S., Micera, A., Bini, S., Berton, M., Esposito, G., & Midena, E. (2015) · Acta Ophthalmologica · doi:10.1111/aos.12812 · Cited by 113
“(Cheung et al. 2012) The results from this study (and others) show that investigation of inflammatory processes in the diabetic eye using AH samples is a feasible approach, and confirmation of the robustness of aqueous sampling in terms of achieved results would be important as less invasive then…”
BackgroundResultInfluentialHippocampal adult neurogenesis: Does the immune system matter?
de Miranda, A. S., Zhang, C., Katsumoto, A., & Teixeira, A. L. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.10.052 · Cited by 113
Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer
Marchesi, F., Locatelli, M., Solinas, G., Erreni, M., Allavena, P., & Mantovani, A. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.007 · Cited by 114
“Although our understanding of the reciprocal interaction between tumor cells and peripheral nerves is still incomplete, neurotrophic factors, adhesion molecules and more recently chemokines have been identified as molecular determinants of PNI (Ayala et al., 2001; Cardona et al., 2006; Gil et al.; Ketterer et al., 200…”
BackgroundInfluentialChemokines in and out of the central nervous system: much more than chemotaxis and inflammation
Cardona, A. E., Li, M., Liu, L., Savarin, C., & Ransohoff, R. M. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107763 · Cited by 102
“For the past 5 years, we have been studying the role of the fractalkine receptor CX3CR1 during CNS inflammation [26].”
BackgroundSelf-citationMicroenvironmental influences of apoptosis in vivo and in vitro
Gregory, C. D., & Pound, J. D. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0485-9 · Cited by 114
Impact on the brain of the inflammatory response to surgery
Saxena, S., & Maze, M. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.03.011 · Cited by 114
Neural stem cells in Parkinson’s disease: a role for neurogenesis defects in onset and progression
Grand, J. N. L., González-Cano, L., Pavlou, M. A. S., & Schwamborn, J. C. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1774-1 · Cited by 111
“vation in a MPTP model of PD are partially mediated by the chemokine receptor CX3CR1 [140], a known regulator of adult neurogenesis [141].”
BackgroundThe role of microglia in brain maintenance: implications for Rett syndrome
Derecki, N. C., Cronk, J. C., & Kipnis, J. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.10.002 · Cited by 100
Characterizing primary human microglia: A comparative study with myeloid subsets and culture models
Melief, J., Sneeboer, M. A. M., Litjens, M., Ormel, P. R., Palmen, S. J. M. C., Huitinga, I., Kahn, R. S., Hol, E. M., & de Witte, L. D. (2016) · Glia · doi:10.1002/glia.23023 · Cited by 100
“CX3CR1 is a membrane-bound molecule that is strongly involved in limiting neurotoxicity and plays an important role in neurogenesis and synaptic pruning (Cardona et al., 2006; Rogers et al., 2011).”
Microglia govern the extinction of acute stress-induced anxiety-like behaviors in male mice
Chen, D., Lou, Q., Song, X.-J., Kang, F., Liu, A., Zheng, C., Li, Y., Wang, D., Qun, S., Zhang, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44704-6 · Cited by 112
“Inthe investigation of the upstream signals that mediate CX3CL1 expression, we identi fi ed the germinal center kinase subfamily III family kinase MST4, a 55-kD serine-threonine kinase highly expressed in the placenta, thymus, lymphocytes, and peripheral blood leukocytes 56,57 .”
An Animal Model of Cortical and Callosal Pathology in Multiple Sclerosis
Mangiardi, M., Crawford, D. K., Xia, X., Du, S., Simon‐Freeman, R., Voskuhl, R. R., & Tiwari‐Woodruff, S. K. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00444.x · Cited by 101
“Microglia-mediated neurotoxicity has been well described in vitro, where activated microglia trigger the production and release of neurotoxic molecules and pro-inflammatory cytokines that lead to severe neuronal dysfunction through axonal loss (16, 60).”
BackgroundMinten, C., Terry, R., Deffrasnes, C., King, N. J. C., & Campbell, I. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049851 · Cited by 100
“Thus, mice with a genetic ablation of CX3CL1 exhibited enhanced microglial activation and neutotoxicity following toxin-induced inflammation and in genetic models of neurodegeneration [34].”
BackgroundUnderstanding the neural repair-promoting properties of olfactory ensheathing cells
Roet, K. C. D., & Verhaagen, J. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.05.007 · Cited by 109
Sandvig, I., Augestad, I. L., Håberg, A. K., & Sandvig, A. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13959 · Cited by 94
Microglia in the developing brain: from immunity to behaviour
Schlegelmilch, T., Henke, K., & Peri, F. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.08.004 · Cited by 120
Afridi, R., Kim, J.-H., Rahman, M. H., & Suk, K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00020 · Cited by 98
Microglial modulation of neuronal activity in the healthy brain
York, E. M., Bernier, L., & MacVicar, B. A. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22571 · Cited by 98
“Finally, neuronal CX3CL1 binds to CX3CR1 expressed on microglia and limits inflammation, process dynamics, and migration (Cardona et al., 2006; Liang et al., 2010b).”
BackgroundCao, Z., Yang, X., Zhang, H., Wang, H., Huang, W., Xu, F., Zhuang, C., Wang, X., & Li, Y. (2016) · Chemosphere · doi:10.1016/j.chemosphere.2016.02.092 · Cited by 105
“Microglial cells are the resident proinflammatory cells of the central nervous system (CNS).”
New Insights into Microglia–Neuron Interactions: A Neuron’s Perspective
Pósfai, B., Cserép, C., Orsolits, B., & Dénes, Á. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.04.046 · Cited by 98
Delpech, J.-C., Madore, C., Joffre, C., Aubert, A., Kang, J. X., Nadjar, A., & Layé, S. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.196 · Cited by 109
“Evaluation of several pathological processes showed that signaling through the fractalkine receptor reduced neuronal damage (Cardona et al, 2006; Ransohoff, 2009).”
BackgroundRidderstad Wollberg, A., Ericsson-Dahlstrand, A., Juréus, A., Ekerot, P., Simon, S., Nilsson, M., Wiklund, S.-J., Berg, A.-L., Ferm, M., Sunnemark, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316510111 · Cited by 97
CX3CL1 Promotes Breast Cancer via Transactivation of the EGF Pathway
Tardáguila, M., Mira, E., García‐Cabezas, M. Á., Feijoo, A. M., Quintela-Fandiño, M., Azcoitia, Í., Lira, S. A., & Mañes, S. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3828 · Cited by 104
Self-citationFrom development to dysfunction: Microglia and the complement cascade in CNS homeostasis
Zabel, M. K., & Kirsch, W. M. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.02.001 · Cited by 97
“Its canonical G protein coupled receptor, CX3CR1, is found only on microglia in the CNS (Cardona et al., 2006).”
Defective microglial development in the hippocampus of Cx3cr1 deficient mice
Pagani, F., Paolicelli, R. C., Murana, E., Cortese, B., Angelantonio, S. D., Zurolo, E., Guiducci, E., Ferreira, T. A., Garofalo, S., Catalano, M., et al. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00111 · Cited by 97
Glia: silent partners in energy homeostasis and obesity pathogenesis
Douglass, J. D., Dorfman, M. D., & Thaler, J. P. (2017) · Diabetologia · doi:10.1007/s00125-016-4181-3 · Cited by 95
“Accordingly, Cx3cr1 deletion in mice causes excess microglial activation and increased susceptibility to CNS inflammatory diseases [43].”
BackgroundThe Role of Anti-Inflammatory Agents in Parkinson???s Disease
McGeer, E. G., & McGeer, P. L. (2007) · CNS Drugs · doi:10.2165/00023210-200721100-00001 · Cited by 95
Ccr2 deletion dissociates cavity size and tau pathology after mild traumatic brain injury
Gyoneva, S., Kim, D., Katsumoto, A., Kokiko-Cochran, O. N., Lamb, B. T., & Ransohoff, R. M. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0443-0 · Cited by 95
“Modulation of inflammation in Cx3cr1 and Ccr2 mice The Cx3cr1 mice that we employed here are commonly used to study and visualize microglia in the brain [29, 34].”
BackgroundMethodSelf-citationIshida, Y., Kimura, A., Nosaka, M., Kuninaka, Y., Hemmi, H., Sasaki, I., Kaisho, T., Mukaida, N., & Kondo, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-17007-8 · Cited by 102
Neuroinflammation in Sepsis: Molecular Pathways of Microglia Activation
Moraes, C., Zaverucha-do-Valle, C., Fleurance, R., Sharshar, T., Bozza, F., & d’Avila, J. (2021) · Pharmaceuticals · doi:10.3390/ph14050416 · Cited by 94
Fenn, A. M., Smith, K. M., Lovett-Racke, A. E., Guerau-de-Arellano, M., Whitacre, C. C., & Godbout, J. P. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.007 · Cited by 95
“CX3CR1 mice have a hyperreactive microglial response to an inflammatory challenge (Cardona et al., 2006) that results in amplified proinflammatory cytokine production, prolonged sickness behavior, and the development of depressive-like behavior (Corona et al.”
BackgroundNeonatal microglia: The cornerstone of brain fate
Pierre, W. C., Smith, P. L. P., Londoño, I., Chemtob, S., Mallard, C. E., & Lodygensky, G. A. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.08.018 · Cited by 110
“, 2000); CX3CL1CX3CR1 (Cardona et al., 2006; Harrison et al., 1998); signal regulatory protein (SIRP)α-CD47”
BackgroundHu, S. J., Calippe, B., Lavalette, S., Roubeix, C., Montassar, F., Housset, M., Levy, O., Delarasse, C., Paques, M., Sahel, J.-A., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3955-14.2015 · Cited by 95
“The results of our study provide an explanation for the increased IL-1 secretion observed in Cx3cr1-deficient MPs (Cardona et al., 2006).”
BackgroundResultInfluentialMinimal NF-κB activity in neurons
Listwak, S. J., Rathore, P., & Herkenham, M. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.013 · Cited by 94
“The failure of induction of CX3CL1 (fractalkine) expression in neurons was surprising because this is a chemokine produced by neurons and thought to hold CX3CR1 receptorbearing microglia in a quiescent state (Cardona et al., 2006).”
BackgroundToxic role of prostaglandin E2 receptor EP1 after intracerebral hemorrhage in mice
Zhao, X., Wu, T., Chang, C.-F., Wu, H., Han, X., Li, Q., Gao, Y., Li, Q., Hou, Z., Maruyama, T., et al. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.02.011 · Cited by 94
Nerves and Pancreatic Cancer: New Insights into A Dangerous Relationship
Gasparini, G., Pellegatta, M., Crippa, S., Lena, M. S., Belfiori, G., Doglioni, C., Taveggia, C., & Falconi, M. (2019) · Cancers · doi:10.3390/cancers11070893 · Cited by 107
“Both neurons and endothelial cells express CX3CL1 [188–190], the unique ligand for the receptor CX3CR1, which in the central nervous system (CNS) is implicated in neurons–microglia cross talk [191,192].”
BackgroundCross-talk between microglia and neurons regulates HIV latency
Alvarez-Carbonell, D., Ye, F., Ramanath, N., García‐Mesa, Y., Knapp, P. E., Hauser, K. F., & Karn, J. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008249 · Cited by 101
“Therefore, microglia-mediated neurotoxicity, appears to be the result of excessive and uncontrolled stimulation [49, 50], and/or impaired functionality of intrinsic molecular mechanisms [51–53], which are likely to be further impaired as a consequence of HIV infection.”
BackgroundCX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity
Sheridan, G. K., Wdowicz, A., Pickering, M., Watters, O., Halley, P., O’Sullivan, N. C., Mooney, C., O’Connell, D. J., O’Connor, J. J., & Murphy, K. J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00233 · Cited by 94
Jurgens, H. A., & Johnson, R. W. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.015 · Cited by 109
“In addition to increasing BDNF, we also found that enrichment increased the expression of CX3CL1 (fractalkine), a chemokine constitutively expressed in the brain, that exerts immunomodulatory and anti-inflammatory effects during acute and chronic neuroinflammation (Cardona et al., 2006; Harrison et al., 1998; Lyons et…”
InfluentialMicroglia: dismantling and rebuilding circuits after acute neurological injury
Ziebell, J. M., Adelson, P. D., & Lifshitz, J. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-014-9539-y · Cited by 84
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis
Rizzo, F., Riboldi, G. M., Salani, S., Nizzardo, M., Simone, C., Corti, S. P., & Hedlund, E. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1480-4 · Cited by 106
“Fractalkine (CX3CL1) signaling promotes a dialogue between motor neurons and microglia, inducing microglia proliferation and chemotaxis; while, a lack of CX3CL1 induces neurotoxicity [120].”
Stress and aging act through common mechanisms to elicit neuroinflammatory priming
Fonken, L. K., Frank, M. G., Gaudet, A. D., & Maier, S. F. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.07.012 · Cited by 93
“The cognate receptor for CD200, CD200R, is exclusively expressed on microglia and other myeloid cells in the CNS (Cardona et al., 2006).”
InfluentialPathologic role of glial nitric oxide in adult and pediatric neuroinflammatory diseases
Ghasemi, M., & Fatemi, A. S. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.06.002 · Cited by 115
Fractalkine/CX 3 CL 1 modulates GABAA currents in human temporal lobe epilepsy
Roseti, C., Fucile, S., Lauro, C., Martinello, K., Bertollini, C., Esposito, V., Mascia, A., Catalano, M., Aronica, E., Limatola, C., et al. (2013) · Epilepsia · doi:10.1111/epi.12354 · Cited by 92
“observations that CX3CL1 reduces the production of the proepileptogenic IL-1b (Cardona et al., 2006).”
BackgroundInfluentialChen, Z., Ross, J. L., & Hambardzumyan, D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902366116 · Cited by 91
Loss of tau rescues inflammation-mediated neurodegeneration
Maphis, N., Xu, G., Kokiko-Cochran, O. N., Cardona, A. E., Ransohoff, R. M., Lamb, B. T., & Bhaskar, K. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00196 · Cited by 91
Self-citationAcute microglia ablation induces neurodegeneration in the somatosensory system
Rubino, S. J., Mayo, L., Wimmer, I., Siedler, V., Brunner, F., Hametner, S., Madi, A., Lanser, A., Moreira, T., Donnelly, D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05929-4 · Cited by 91
Fractalkine Modulates Microglia Metabolism in Brain Ischemia
Lauro, C., Chece, G., Monaco, L., Antonangeli, F., Peruzzi, G., Rinaldo, S., Paone, A., Cutruzzolà, F., & Limatola, C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00414 · Cited by 91
“CX3CL1 has been reported to inhibit the release of inflammatory cytokines (Zujovic et al., 2000; Mizuno et al., 2003; Cardona et al., 2006) and reduce microglia activation, keeping these cells in what (before the deep use of transcriptome analysis) has been defined an “off” state (Biber et al.”
BackgroundOptic Nerve Degeneration after Retinal Ischemia/Reperfusion in a Rodent Model
Renner, M., Stute, G., Alzureiqi, M., Reinhard, J., Wiemann, S., Schmid, H., Faissner, A., Dick, H. B., & Joachim, S. C. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00254 · Cited by 107
“A theory implies that in an overactivated and dysregulated state, microglia aggravate an already existing damage by promoting a second disease course (Cardona et al., 2006; Block et al., 2007).”
BackgroundFractalkine: moving from chemotaxis to neuroprotection
Ré, D. B., & Przedborski, S. (2006) · Nature Neuroscience · doi:10.1038/nn0706-859 · Cited by 93
Ohsawa, K., & Kohsaka, S. (2011) · Glia · doi:10.1002/glia.21238 · Cited by 91
“, CD22-CD45 (Mott et al., 2004), CD172A-CD47 (Barclay et al., 2002; Junker et al., 2009), CX3CL1-CX3CR1 (Cardona et al., 2006; Harrison et al., 1998; Hundhausen et al., 2003), and *Correspondence to: Shinichi Kohsaka., Department of Neurochemistry, National Institute of Neuroscience, 4-1-1 Ogawahigashi, Kodaira, Tokyo…”
A Spirulina-Enhanced Diet Provides Neuroprotection in an α-Synuclein Model of Parkinson's Disease
Pabon, M. M., Jernberg, J. N., Morganti, J., Contreras, J., Hudson, C. E., Klein, R. L., & Bickford, P. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045256 · Cited by 90
“CX3CR1 is a chemokine receptor that when stimulated, leads to reduced synthesis of pro-inflammatory cytokines IL1b and TNFa [29].”
BackgroundGlucocorticoids Increase Excitotoxic Injury and Inflammation in the Hippocampus of Adult Male Rats
Sorrells, S. F., Munhoz, C. D., Manley, N. C., Yen, S., & Sapolsky, R. M. (2014) · Neuroendocrinology · doi:10.1159/000367849 · Cited by 97
Freria, C. M., Hall, J. C. E., Wei, P. Y., Guan, Z., McTigue, D. M., & Popovich, P. G. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2841-16.2017 · Cited by 100
“Chemokine receptors are another class of receptors that may regulate divergent functions in microglia and MDMs after SCI. Previously, we found that deletion of CX3CR1, a chemokine receptor that binds only to fractalkine (CX3CL1), improves functional recovery and reduces lesion pathology after SCI in mice (Donnelly et…”
BackgroundMethodInfluentialTrettel, F., Di Castro, M. A., & Limatola, C. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2019.07.035 · Cited by 89
Ali, I. Y., Chugh, D., & Ekdahl, C. T. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.11.009 · Cited by 93
“The mixed reports including both increased and decreased activation of microglia in response to inhibition of the fractalkine–CX3CR1 pathway in a pathological brain environment has already been suggested to depend on the severity and chronicity of the insult (Cardona et al., 2006).”
Metadata
- Authors
- Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., Lee, J.-C., Cook, D. N., Jung, S., Lira, S. A., Littman, D. R., & Ransohoff, R. M.
- Affiliations
- Cleveland Clinic (US)
- National Institute of Environmental Health Sciences (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Ransohoff, Richard M
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-06-18
- Volume
- 9
- Issue
- 7
- Pages
- 917-924
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2113107925
- Cited by
- 1,531
- References
- 39
- Citations by year
- 2026: 46 · 2025: 44 · 2024: 84 · 2023: 62 · 2022: 83 · 2021: 73 · 2020: 66 · 2019: 76 · 2018: 95 · 2017: 90 · 2016: 87 · 2015: 102 · 2014: 133 · 2013: 104 · 2012: 90
- FWCI
- 32.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS32151, R01NS032151)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- microglia, CX3CR1, microglial neurotoxicity, neuroinflammation, lipopolysaccharide, Parkinson's disease, amyotrophic lateral sclerosis, neuronal loss, CX3CR1 knockout mice
- MeSH terms
- CX3C Chemokine Receptor 1, Analysis of Variance, Animals, Calcium-Binding Proteins, Cells, Cultured, Central Nervous System, Disease Models, Animal, Flow Cytometry, Immunohistochemistry, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Nerve Tissue Proteins, Neurons, Parkinson Disease, Cytokines, Motor Neuron Disease, Cell Death, Microglia, Receptors, Chemokine, Neurotoxicity Syndromes, Green Fluorescent Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.